Patents
Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
05/2002
05/28/2002US6395491 Coding and storing information on substrate; code biopolymer sequence, attach to substrate, recover information by replication of biopolymer sequence
05/28/2002CA2248006C Activated linkers and methods for making and purifying the same
05/23/2002WO2001077687A3 Prion-binding peptidic ligands and methods of using same
05/22/2002EP0606317B1 Saponin-antigen conjugates and the use thereof
05/14/2002US6387698 Polyclonal antiserum produced by immunzing animal with tumor rejection antigen precursor
05/14/2002CA2167090C Compositions and methods for stimulating megakaryocyte growth and differentiation
05/10/2002WO2001046213A3 Compound comprising a peptide moiety and an organo-silane moiety.
05/09/2002US20020055614 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
05/09/2002US20020055174 Complex for transferring an anionic substance of interest into a cell
05/09/2002US20020054879 Reacting protein with polysaccharide to produce mixture including protein-polysaccharide conjugate and free protein
05/09/2002US20020054871 Treating a host suffering from hyperlipidemia resulting from elevated levels of at least one of very low density lipoproteins and triglycerides and effective amount of an agent that reduces the level of active apolipoprotein E
05/08/2002EP1203958A2 High-throughput screening method
05/07/2002US6384195 Produced by partitioning method; therapeutics
05/07/2002US6384189 Compositions for stimulating TGF-β activity
05/07/2002US6383584 Carriers, immobilization
05/02/2002WO2002034915A2 Preferred segments of neural thread protein and methods of using the same
05/02/2002WO2001018172A3 Fibroblast growth factor-like polypeptides
05/02/2002US20020052594 Method and kit for imaging and treating organs and tissues
05/02/2002US20020052481 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4 -IgG2 immunoconjugates, and uses thereof
05/02/2002US20020052443 Non-antigenic branched polymer conjugates
05/02/2002US20020052000 Diagnostics for and mediators of inflammatory disorders
05/02/2002EP1200617A2 Methods for conditional transgene expression and trait removal in plants
05/02/2002CA2427070A1 Preferred segments of neural thread protein and methods of using the same
04/2002
04/30/2002US6380154 Synthetic proteins for in vivo drug delivery and tissue augmentation
04/30/2002US6379901 Detecting cancer cells that express a human leukocyte antigen molecule using a nonapeptide derived from the tumor rejection antigen precursor; mixing cells and nonapeptide to form complexes; expose to cytolytic cells and determine lysis
04/30/2002US6379895 Photolithographic and other means for manufacturing arrays
04/25/2002WO2002033116A2 Nucleic acid ligands to the prostate specific membrane antigen
04/25/2002WO2002032963A1 Immunoadjuvant systems
04/25/2002WO2002032943A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
04/25/2002WO2002032925A2 Protein scaffolds for antibody mimics and other binding proteins
04/25/2002US20020049152 Generally in the same orientation, can be full-length and biologically active, and can be readily screened for a desired activity.
04/25/2002CA2425605A1 Nucleic acid ligands to the prostate specific membrane antigen
04/25/2002CA2418835A1 Protein scaffolds for antibody mimics and other binding proteins
04/24/2002EP1137812A4 Dna-protein fusions and uses thereof
04/24/2002EP0856155B1 Fluorescent and luminescent labelling compositions and methods for their use
04/24/2002EP0851768B1 Interactive molecular conjugates
04/24/2002EP0733126B1 Immobilized mismatch binding protein for detection or purification of mutations or polymorphisms
04/24/2002CN1346280A Immunoadsorber for use in sepsis therapy
04/18/2002WO2002009793A8 Device for treating immune diseases
04/18/2002US20020045567 Synthetic proteins for in vivo drug delivery and tissue augmentation
04/18/2002US20020044937 Where the protein binds to T-cell cell surface protein, and that complex with nucleic acids, for transporting nucleic acids into human or animal cells which express the T-cell surface protein; antisense therapy, HIV therapy
04/18/2002US20020044893 Made using a reversible protecting group to reversibly modify omega-functionalized alkanethiols self-assembled on metal substrates, and immobilizing cells or biomolecules; use in surface plasmon resonance (SPR) imaging
04/17/2002EP1196637A1 Peptide acceptor ligation methods
04/17/2002EP1196442A1 Vgf polypeptides and methods of treating vgf-related disorders
04/17/2002EP1196191A1 Death domain containing receptor 5
04/17/2002EP1056882A4 One dimensional chemical compound arrays and methods for assaying them
04/17/2002CN1082821C Antibody cojugates
04/11/2002WO2002028895A2 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator
04/11/2002WO2002028437A1 Regioselective liquid phase pegylation
04/11/2002WO2001019405A3 Magnetic nanoparticles having biochemical activity, method for the production thereof and their use
04/11/2002CA2424506A1 Cyclopeptides, a method for their preparation and their use as inhibitors or activators of angiogenesis
04/11/2002CA2422707A1 Regioselective liquid phase pegylation
04/10/2002CN1343887A Process for preparing antigen microarray based on self antibody repertoire
04/09/2002US6368877 Self-assembling peptide surfaces for cell patterning and interactions
04/04/2002WO2001012232A3 Process to make a sustained release formulation
04/02/2002US6365158 Immunizing avian host with purified recombinant fusion protein comprising non-toxin protein sequence and portion of clostridium difficile toxin b sequence so as to generate neutralizing antitoxin
04/02/2002US6365156 Contacting mucosal membrane of animal with chimeric molecule comprising viral-specific ligand and bacterial-specific ligand which is specific for bacteria colonizing membrane
03/2002
03/28/2002WO2002024325A2 Acoustic ejection of fluids from a plurality of reservoirs
03/28/2002WO2000043791A9 Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases
03/27/2002EP0730470B1 Improved interferon polymer conjugates
03/26/2002US6362011 For detection and quantitation of analytes of interest in biochemical and biological substances; for conducting binding assays by measuring luminescence emitted by one or more labeled components of the assay system
03/26/2002US6361974 Exonuclease-mediated nucleic acid reassembly in directed evolution
03/21/2002WO2001098324A8 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
03/21/2002US20020034755 Polypeptides having a functional domain of interest and methods of identifying and using same
03/20/2002EP1187626A1 Methods for producing 5'-nucleic acid-protein conjugates
03/20/2002EP1005495B1 Aminoalkyl trialkyl silyl cellulose and a method for coating surfaces
03/20/2002CN1341120A 骨刺激因子 Bone stimulator
03/14/2002WO2002020769A1 Human and mouse targeting peptides identified by phage display
03/14/2002WO2002020034A1 'pseudo'-native chemical ligation
03/14/2002WO2002020033A1 Polymer-modified synthetic proteins
03/14/2002WO2002019963A2 Synthetic erythropoiesis stimulating proteins
03/14/2002US20020032157 Methods of inhibiting ectopic calcification
03/14/2002CA2412279A1 "pseudo"-native chemical ligation
03/14/2002CA2412278A1 Polymer-modified synthetic proteins
03/14/2002CA2412277A1 Synthetic erythropoiesis stimulating proteins
03/13/2002CN1080575C Conjugation-stablized polypeptide compositions, therapeutic delivery and disgnostic formulations comprising same, and method of making and using the same
03/12/2002US6355432 Collection of plurality of beads which have binding polymers of different target specific sequence attached thereto; said beads being coded with encoding system whereby target specific sequence of polymer attached to beads can be identified
03/07/2002WO2002018443A2 A recombinant monoclonal antibody to phosphotyrosine-containing proteins
03/07/2002US20020028914 Chimeric toxins for targeted therapy
03/07/2002CA2420876A1 A recombinant monoclonal antibody to phosphotyrosine-containing proteins
03/06/2002EP1183271A1 Polymer conjugates of hedgehog proteins and uses
03/06/2002EP1183049A2 Modification of biological elements
03/06/2002CN1080124C Pneumococcal polysaccharide conjugate vaccine
03/05/2002US6352842 Exonucease-mediated gene assembly in directed evolution
02/2002
02/28/2002WO2002016945A1 Chemical sensor and method of detecting chemical
02/28/2002WO2002016571A1 Magnetic particles having lower limit critical solution temperature
02/28/2002WO2001038547A3 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells
02/28/2002US20020026044 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing
02/27/2002EP1182458A1 Method for detecting proteins under mutual interaction
02/27/2002EP0786087B1 Polypeptide-dendrimer complexes
02/26/2002US6350854 Isolated 55 to 72 kDa protein which binds to prion proteins
02/21/2002WO2002013775A1 Dental products comprising bone growth enhancing peptide
02/21/2002US20020022033 Diagnosis of Aids
02/21/2002DE10036742A1 Vorrichtung zur Behandlung von Immunerkrankungen Apparatus for the treatment of immune diseases
02/14/2002WO2002012893A2 Microarrays of functional biomolecules, and uses therefor
02/14/2002WO2000073337A9 Polymer conjugates of hedgehog proteins and uses
02/14/2002CA2418105A1 Microarrays of functional biomolecules, and uses therefor
02/13/2002EP0859793B1 Conjugation of ligand to immobilized protein in organic solvent
02/13/2002CN1335505A Protein chip based on labeling streptavidin-biotin technology
02/13/2002CN1335504A Protein chip for immunological analysis
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 107